Looking to sell SWORD Health stock or options?
SWORD Health is a developer of an AI-driven care platform that offers personalized rehabilitation services to patients worldwide. The platform allows patients to engage in interactive physical therapy exercises from the comfort of their homes, while being monitored by remote physiotherapists. This approach not only assists patients in completing their physical therapy but also helps to lower costs. SWORD Health enables patients to access a wealth of data, empowering them to undertake therapy independently.
UTEN Portugal, BPEA Private Equity, Founders Fund, EQT Private Capital Asia, Faber Ventures, Capitalis Partners, Sozo Ventures, Lince Capital, Phoenix Court, ADQ, Willoughby Capital, Sapphire Ventures, Transformation Capital, Locapes Investment Fund, Spearhead (VC), Earl Grey Capital, Partners Group, Lachy Groom, Ativar Portugal, Green Innovations, Horizon 2020 SME Instrument, BOND Capital (San Francisco), Oxy Capital, Khosla Ventures, Highmark Ventures.
SWORD Health is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize SWORD Health stock. Depending on SWORD Health’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange SWORD Health stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of SWORD Health stock in two ways. First, SWORD Health employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your SWORD Health stock. Note that all transactions in SWORD Health shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
SWORD Health stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for SWORD Health stock. Typically, shares of private companies like SWORD Health are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On Jun 2024, SWORD Health is reported to have closed an equity financing in which the investors valued the company at $3.0B. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of SWORD Health shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because SWORD Health is not currently publicly traded, it does not have a ticker symbol.
SWORD Health has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though SWORD Health is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on SWORD Health shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.